Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1995;25:720-725

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ichiki, T.
Right arrow Articles by Inagami, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ichiki, T.
Right arrow Articles by Inagami, T.

(Hypertension. 1995;25:720-725.)
© 1995 American Heart Association, Inc.


Articles

Transcriptional Regulation of the Mouse Angiotensin II Type 2 Receptor Gene

Toshihiro Ichiki; Tadashi Inagami

From the Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tenn.

Correspondence to Tadashi Inagami, Dept of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232.

Abstract The promoter region of the mouse angiotensin II type 2 receptor gene was cloned, and the nucleotide sequences were determined. A computer homology search for a 1.5-kb promoter region showed that there are several consensus cis DNA elements such as C/EBP, NF-IL6, and AP-1 in this region. Primer extension experiments showed that there are two transcription initiation sites 16 bp apart in the mouse type 2 receptor gene. Deletion mutants of this 1.5-kb segment were prepared and fused to a luciferase reporter gene. These type 2 receptor promoter–luciferase constructs were introduced into PC12W cells, which are from a pheochromocytoma cell line expressing the type 2 receptor, and luciferase activity was measured. It showed that a DNA segment between nucleotides -1497 and -874 suppresses the promoter activity of the type 2 receptor gene and that a DNA segment between nucleotides -47 and +56 is important for the basal promoter activity of the type 2 receptor gene. This proximal segment showed very weak promoter activity when introduced into vascular smooth muscle cells. Gel mobility shift assay with nuclear extracts from PC12W cells showed the presence of three DNA binding proteins that bound to a DNA probe between nucleotides -47 and +8. One DNA binding protein was only very weakly expressed in nuclear extracts from vascular smooth muscle cells, which do not express the type 2 receptor. Two other DNA binding proteins were not observed in nuclear extracts from vascular smooth muscle cells. These data suggest that this DNA segment between nucleotides -47 and +56 is important not only for basal transcription but for differential expression of the type 2 receptor gene in PC12W cells and vascular smooth muscle cells.


Key Words: angiotensin II • type 2 receptor (AT2) • promoter regions (genetics) • DNA binding protein




This article has been cited by other articles:


Home page
EndocrinologyHome page
A. Chakrabarty, A. Blacklock, S. Svojanovsky, and P. G. Smith
Estrogen Elicits Dorsal Root Ganglion Axon Sprouting via a Renin-Angiotensin System
Endocrinology, July 1, 2008; 149(7): 3452 - 3460.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
I. Armando, M. Jezova, A. V. Juorio, J. A. Terron, A. Falcon-Neri, C. Semino-Mora, H. Imboden, and J. M. Saavedra
Estrogen upregulates renal angiotensin II AT2 receptors
Am J Physiol Renal Physiol, November 1, 2002; 283(5): F934 - F943.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. Zhu, C. Sumners, C. H. Gelband, and P. Posner
Chronotropic Effect of Angiotensin II via Type 2 Receptors in Rat Brain Neurons
J Neurophysiol, May 1, 2001; 85(5): 2177 - 2183.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Matsubara
Pathophysiological Role of Angiotensin II Type 2 Receptor in Cardiovascular and Renal Diseases
Circ. Res., December 14, 1998; 83(12): 1182 - 1191.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Ohkubo, H. Matsubara, Y. Nozawa, Y. Mori, S. Murasawa, K. Kijima, K. Maruyama, H. Masaki, Y. Tsutumi, Y. Shibazaki, et al.
Angiotensin Type 2 Receptors Are Reexpressed by Cardiac Fibroblasts From Failing Myopathic Hamster Hearts and Inhibit Cell Growth and Fibrillar Collagen Metabolism
Circulation, December 2, 1997; 96(11): 3954 - 3962.
[Abstract] [Full Text]


Home page
HypertensionHome page
G. Koike, E. S. Winer, M. Horiuchi, D. M. Brown, C. Szpirer, V. J. Dzau, and H. J. Jacob
Cloning, Characterization, and Genetic Mapping of the Rat Type 2 Angiotensin II Receptor Gene
Hypertension, December 1, 1995; 26(6): 998 - 1002.
[Abstract] [Full Text]